Phanes Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $40M

  • Investors
  • 7

Phanes Therapeutics General Information

Description

Operator of a biotechnology company intended to focus on drug discovery and early development in immuno-oncology. The company develops native Immunoglobulin G-like bispecific antibodies that enhance drug-like properties to a cure, enabling patients to access new drugs more efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 400
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 400
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phanes Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 06-May-2021 $40M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 01-Nov-2018 Completed Startup
To view Phanes Therapeutics’s complete valuation and funding history, request access »

Phanes Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Phanes Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phanes Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to focus on drug discovery and early development in immuno-oncology. The co
Drug Discovery
San Diego, CA
29 As of 2026

Watertown, MA
 

Weston, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phanes Therapeutics Competitors (72)

One of Phanes Therapeutics’s 72 competitors is Kymera Therapeutics, a Formerly VC-backed company based in Watertown, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymera Therapeutics Formerly VC-backed Watertown, MA
Cantex Pharmaceuticals Formerly VC-backed Weston, FL
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Precigen Formerly VC-backed Germantown, MD
Byondis Corporation Nijmegen, Netherlands
You’re viewing 5 of 72 competitors. Get the full list »

Phanes Therapeutics Patents

Phanes Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025147472-A1 Anti-611-ctf p95her2 antibodies and uses thereof Inactive 02-Jan-2024
WO-2024182475-A2 Anti-ror2 antibodies and uses thereof Inactive 02-Mar-2023
WO-2024182475-A3 Anti-ror2 antibodies and uses thereof Inactive 02-Mar-2023
EP-4615501-A1 Anti-5t4 antibodies and uses thereof Pending 08-Nov-2022
US-20260167739-A1 Anti-5t4 antibodies and uses thereof Pending 08-Nov-2022 C07K16/30
To view Phanes Therapeutics’s complete patent history, request access »

Phanes Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phanes Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Delos Capital Partners Venture Capital Minority
DYEE Capital Asset Manager Minority
HSG (Hong Kong) Venture Capital Minority
Sequoia Capital Venture Capital Minority
Volcanics Venture Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Phanes Therapeutics FAQs

  • When was Phanes Therapeutics founded?

    Phanes Therapeutics was founded in 2016.

  • Where is Phanes Therapeutics headquartered?

    Phanes Therapeutics is headquartered in San Diego, CA.

  • What is the size of Phanes Therapeutics?

    Phanes Therapeutics has 29 total employees.

  • What industry is Phanes Therapeutics in?

    Phanes Therapeutics’s primary industry is Drug Discovery.

  • Is Phanes Therapeutics a private or public company?

    Phanes Therapeutics is a Private company.

  • What is Phanes Therapeutics’s current revenue?

    The current revenue for Phanes Therapeutics is .

  • How much funding has Phanes Therapeutics raised over time?

    Phanes Therapeutics has raised $55M.

  • Who are Phanes Therapeutics’s investors?

    Delos Capital Partners, DYEE Capital, HSG (Hong Kong), Sequoia Capital, and Volcanics Venture are 5 of 7 investors who have invested in Phanes Therapeutics.

  • Who are Phanes Therapeutics’s competitors?

    Kymera Therapeutics, Cantex Pharmaceuticals, CytomX Therapeutics, Precigen, and Byondis are some of the 72 competitors of Phanes Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process